Upregulation of Id1 by Epstein-Barr Virus-encoded LMP1 confers resistance to TGFβ-mediated growth inhibition

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Lo, Angela K F ^a   Dawson, Christopher W ^a   Lo, Kwok W ^b   Yu, Yanxing ^c   Young, Lawrence S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; INHIBITOR OF DIFFERENTIATION 1; LATENT MEMBRANE PROTEIN 1; PROTEIN P21; SMAD PROTEIN; TRANSCRIPTION FACTOR FKHRL1; TRANSFORMING GROWTH FACTOR BETA; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; ID1 PROTEIN, HUMAN; MATRIX PROTEIN; PRIMER DNA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSTASIS; EPSTEIN BARR VIRUS; GROWTH INHIBITION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION; UPREGULATION; CELL CYCLE; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

HUMAN HERPESVIRUS 4;

BASE SEQUENCE; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; DNA PRIMERS; FORKHEAD TRANSCRIPTION FACTORS; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; VIRAL MATRIX PROTEINS;

EID: 77955124555     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-155     Document Type: Article

References (36)

1. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002, 12:431-441. 10.1016/S1044579X0200086X, 12450729.
2. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757-768. 10.1038/nrc1452, 15510157.
3. Tsao SW, Tramoutanis G, Dawson CW, Lo AK, Huang DP. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin Cancer Biol 2002, 12:473-487. 10.1016/S1044579X02000901, 12450733.
4. Yang JY, Hung MC. A new fork for clinical application: targeting forkhead transcription factors in cancer. Clin Cancer Res 2009, 15:752-757. 10.1158/1078-0432.CCR-08-0124, 2676228, 19188143.
5. Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007, 7:847-859. 10.1038/nrc2223, 17943136.
6. Birkenkamp KU, Essafi A, van der Vos KE, da Costa M, Hui RC, Holstege F, Koenderman L, Lam EW, Coffer PJ. FOXO3a induces differentiation of Bcr-Abl-transformed cells through transcriptional down-regulation of Id1. J Biol Chem 2007, 282:2211-2220. 10.1074/jbc.M606669200, 17132628.
7. Ling MT, Wang X, Zhang X, Wong YC. The multiple roles of Id-1 in cancer progression. Differentiation 2006, 74:481-487. 10.1111/j.1432-0436.2006.00083.x, 17177845.
8. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007, 1775:21-62.
9. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003, 3:807-821. 10.1038/nrc1208, 14557817.
10. Arvanitakis L, Yaseen N, Sharma S. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J Immunol 1995, 155:1047-1056.
11. Takanashi M, Li J, Shirakata M, Mori S, Hirai K. Tumorigenicity of mouse BALB/c 3T3 fibroblast cells which express Epstein-Barr virus-encoded LMP1 and show normal growth phenotypes in vitro is correlated with loss of transforming growth factor-beta 1-mediated growth inhibition. Arch Virol 1999, 144:241-257. 10.1007/s007050050501, 10470251.
12. Prokova V, Mosialos G, Kardassis D. Inhibition of transforming growth factor beta signaling and Smad-dependent activation of transcription by the Latent Membrane Protein 1 of Epstein-Barr virus. J Biol Chem 2002, 277:9342-9350. 10.1074/jbc.M109099200, 11781310.
13. Mori N, Morishita M, Tsukazaki T, Yamamoto N. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB. Int J Cancer 2003, 105:661-668. 10.1002/ijc.11146, 12740915.
14. Chen YR, Liu MT, Chang YT, Wu CC, Hu CY, Chen JY. Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells. J Virol 2008, 82:8124-8137. 10.1128/JVI.00430-08, 2519561, 18524825.
15. Everly DN, Mainou BA, Raab-Traub N. The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation. Virology 2008, 376:258-269. 10.1016/j.virol.2007.12.003, 18456300.
16. Everly DN, Mainou BA, Raab-Traub N. Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol 2004, 78:13470-13478. 10.1128/JVI.78.24.13470-13478.2004, 533955, 15564458.
17. Li HM, Zhuang ZH, Wang Q, Pang JC, Wang XH, Wong HL, Feng HC, Jin DY, Ling MT, Wong YC, et al. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 2004, 23:4488-4494. 10.1038/sj.onc.1207580, 15064751.
18. Wong YC, Wang X, Ling MT. Id-1 expression and cell survival. Apoptosis 2004, 9:279-289. 10.1023/B:APPT.0000025804.25396.79, 15258459.
19. Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, Zheng Z, Wong N, Yuen PW, Lo AK, Wong YC, et al. Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 2002, 1590:150-158. 10.1016/S0167-4889(02)00208-2, 12063178.
20. Kang Y, Chen CR, Massague J. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 2003, 11:915-926. 10.1016/S1097-2765(03)00109-6, 12718878.
21. Ikushima H, Komuro A, Isogaya K, Shinozaki M, Hellman U, Miyazawa K, Miyazono K. An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-beta signalling. EMBO J 2008, 27:2955-2965. 10.1038/emboj.2008.218, 2570476, 18923419.
22. Lo AK, Huang DP, Lo KW, Chui YL, Li HM, Pang JC, Tsao SW. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. Int J Cancer 2004, 109:919-925. 10.1002/ijc.20051, 15027126.
23. Ciarrocchi A, Jankovic V, Shaked Y, Nolan DJ, Mittal V, Kerbel RS, Nimer SD, Benezra R. Id1 restrains p21 expression to control endothelial progenitor cell formation. PLoS One 2007, 2:e1338. 10.1371/journal.pone.0001338, 2129121, 18092003.
24. Chambers RC, Leoni P, Kaminski N, Laurent GJ, Heller RA. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 2003, 162:533-546. 1851161, 12547711.
25. Wiercinska E, Wickert L, Denecke B, Said HM, Hamzavi J, Gressner AM, Thorikay M, ten Dijke P, Mertens PR, Breitkopf K, et al. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology 2006, 43:1032-1041. 10.1002/hep.21135, 16628634.
26. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 2002, 21:1743-1753. 10.1093/emboj/21.7.1743, 125949, 11927558.
27. Li Y, Yang J, Luo JH, Dedhar S, Liu Y. Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1. J Am Soc Nephrol 2007, 18:449-460. 10.1681/ASN.2006030236, 17202424.
28. Huang X, Li X, Guo B. KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3. J Biol Chem 2008, 283:29795-29801. 10.1074/jbc.M802515200, 2573052, 18755691.
29. Bottone FG, Moon Y, Kim JS, Alston-Mills B, Ishibashi M, Eling TE. The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3). Mol Cancer Ther 2005, 4:693-703. 10.1158/1535-7163.MCT-04-0337, 15897233.
30. Syed V, Mukherjee K, Lyons-Weiler J, Lau KM, Mashima T, Tsuruo T, Ho SM. Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 2005, 24:1774-1787. 10.1038/sj.onc.1207991, 15674352.
31. Charvet C, Alberti I, Luciano F, Jacquel A, Bernard A, Auberger P, Deckert M. Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteases. Oncogene 2003, 22:4557-4568. 10.1038/sj.onc.1206778, 12881712.
32. Rosas M, Birkenkamp KU, Lammers JW, Koenderman L, Coffer PJ. Cytokine mediated suppression of TF-1 apoptosis requires PI3K activation and inhibition of Bim expression. FEBS Lett 2005, 579:191-198. 10.1016/j.febslet.2004.11.074, 15620712.
33. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC, et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 2008, 10:138-148. 10.1038/ncb1676, 2376808, 18204439.
34. Inoue T, Kamiyama J, Sakai T. Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements. J Biol Chem 1999, 274:32309-32317. 10.1074/jbc.274.45.32309, 10542271.
35. Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To KF, Hayward DS, Chui YL, Lau YL, Takada K, et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 2006, 8:173-180. 10.1593/neo.05625, 1578522, 16611410.
36. Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao G, Hayward SD. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci USA 2007, 104:16164-16169. 10.1073/pnas.0702896104, 2042179, 17911266.